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Underlying 
Pathophysiology
According to the Centers for Disease 
Control, the signs and symptoms of 
Hepatitis B are:
• Fever
• Fatigue
• Joint pain
• Nausea
• Vomiting
• Loss of appetite
• Abdominal Pain
• Dark urine
• Clay colored Stools
• Jaundice
They also identified the following as at-
risk populations:
• Intravenous drug users
• HIV positive patients
• Men who have sex with men
• Person requiring 
immunosuppressive therapy
• Blood and tissue donors
• Infants born to mothers who are 
hepatitis B positive
• Persons with end stage renal 
disease
• Foreign born persons
As well, those who work in healthcare 
may be at increased risk of contraction 
due to exposure to body fluids from 
patients who may be Hepatitis B 
positive. Many healthcare organizations 
require that employees be 
vaccinated for Hepatitis B or have 
records of previous vaccination. As 
well, titers to confirm immunity may be 
required if vaccination has not been 
recent.
When one chooses a career in 
healthcare, they know that there is a 
chance of exposure to harmful diseases 
and germs. To better reduce the chances 
of contracting some of these diseases, 
vaccinations have become required for 
those with the potential to be exposed; 
one of these diseases is hepatitis B (HBV). 
While the number of acute hepatitis B 
infections has been decreasing, in 2016 
the Centers for Disease Control (CDC) 
reported that there was still 1 case per 
100,000 people (2019). According to the 
CDC, healthcare workers are some of the 
most at-risk individuals to contract this 
disease, as the virus is transmitted by 
“blood and blood containing body fluids” 
(2019). This paper will look at the 
disease process, pathophysiology, and 
implications for nurses of hepatitis B 
and discuss actions that can reduce the 
risk of transmission to healthcare 
workers, as well as their patients.
According to Branstetter-Hall & 
Felicilda-Reynaldo, hepatitis B is a virus 
that has its own deoxyribonucleic acid 
(DNA) sequence that infects the normal 
cells of the body, mainly the liver, and 
replicates the infected cells growing the 
virus. Many of these cells move to the liver 
where newly infected cells are made and 
can adapt. This change from producing 
normal liver cells to making these infected 
cells damages the liver. When these cells 
form, they also create several different 
antigens and antibodies that can be 
detected in the blood of those who are 
infected. The antibodies that are formed 
after someone is infected include IgM and 
several different varieties of IgG anti-HB.
As previously stated, titers can be 
drawn to check levels of immunity from 
HBV and these titers look at the antibody 
IgG Anti-HB to see if levels are high enough 
to indicate immunity. There are also four 
stages of HBV, which include the immune 
tolerant phase, immune active phase, 
inactive carrier phase, as well as the 
reactivation phase. Many times, patients do 
not know that they have the virus and do 
not seek care until they have reached the 
immune active phase. In this phase, the 
immune system realizes that it has been 
compromised and starts to combat the 
infection at the expense of the liver. This is 
the phase that can cause the most serious 
complications, such as cancer and cirrhosis 
( 2017).
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In conclusion, due to the disease 
process, there are many different 
aspects that need to be addressed for 
the patient. The patient in the scenario 
would need to have labs and CT scans 
to rule out other abdominal issues or 
differential diagnosis. After a hepatitis 
panel is ran, and if it comes back 
positive, there will need to be a decision 
whether this episode is acute or 
chronic, and then from there the plan of 
care can be developed. As stated by 
Abara, Harris, McMahon, Qaseem,& 
Schillie, the patient will need to be set 
up with not just counseling for the HBV, 
but also possible rehab for the 
intravenous drug use if the patient is 
wanting these services (2017). If the 
patient is not interested in possible 
rehab, they will need to be educated on 
the use of clean needles and reducing 
the spread of the disease. The patient 
will need to discuss the use of antivirals 
and the compliance with them. He will 
need to be educated that because of the 
HBV, he is at increased risk for other 
liver related issues, such as cirrhosis 
and cancer. He will need to follow up 
with a specialist to monitor his liver 
enzymes in the future, as well as make 
sure that the hepatitis does not recur.
Conclusion
Significance of underlying pathophysiology
In terms of caring for patients, there 
needs to be education on HBV available 
to patients and families, so that there is 
not a spread of the virus in the 
household or among sexual partners. 
The nurse would also want to make 
sure that the patient is aware that they 
will need to follow up with a specialist 
to monitor liver enzymes, as well as 
hepatitis panels. In terms of 
prevention, nurses need to educate all 
patients on the need to have the vaccine 
series and to keep up to date on all 
shots. Nurses would also need to 
educate on precautions for those 
diagnosed with HBV on liver protection 
protocols, such as limited use alcoho,l as 
well as limited use of Tylenol and other 
medications that can cause damage to 
the already injured liver.
One would also want to educate the 
patient on what type of medications 
they will be going home with. According 
to the Mayo Clinic website, these can 
include medications such as the 
antivirals that were discussed prior and 
the over the counter options that they 
may utilize. Depending on the acuity of 
the infection, the recommendation may 
be to just rest, increase fluids, and make 
sure that the patient is eating a healthy 
nutritious diet (2019).
As nurses caring for those who have 
been diagnosed with HBV, we have to 
take extra precautions. These include 
donning personal protective equipment 
when there is a possibility of being 
exposed to bodily fluids of those 
patients who may be infected. Another 
precaution to consider is to stay up to 
date on shots, as well as making sure 
that titers are drawn to verify that there 
has not been a breakthrough infection. 
As well, in the rare case that a 
healthcare worker is infected with 
HBV, they will need to follow similar 
precautions as patients. According to 
Enfield, Lewis, & Sifri, they will need to 
use standard precautions when coming 
in contact with patients. They also state 
that there is no governing body of 
healthcare that prohibits the practice of 
workers who are HBV positive (2015).
Case Presentation
A 23-year-old male comes to the 
emergency department with complaints 
of abdominal pain, decreased appetite, 
as well as dark urine for approximately 
6 weeks. The nurse notes on exam that 
the patients' skin and sclera have a 
yellow discoloration, as well as track 
marks noted to arms. When 
questioned, the patient states that he is 
an intravenous drug user, and that he is 
unsure if the needles he has been using 
have been clean. He is also unsure if he 
has been vaccinated for hepatitis in the 
past. Upon exam, nurse notes that 
the patient has tenderness on palpation 
to right upper quad and believes that 
she able to palpate the liver. Patient 
develops nausea and vomiting while in 
emergency department. Also, Patient 
had a bowel movement that was 
discolored which he reports has been 
going on for approximately 2 weeks. 
Heart sounds are within normal limits, 
no murmur or other irregularities 
noted. Lung sounds are clear in all 
fields. No swelling noted to extremities. 
Skin is yellow, warm, and clammy. Vital 
signs are as follows: heart rate is 103, 
respirations are 18, blood pressure is 
123/83, oxygenation is 98 percent, and 
temperature is 102.1. The nurse is 
suspicious of Hepatitis B. The nurse 
must now produce a plan of care for the 
patient and explore possible treatment 
and look at prevention methods for 
recurring infections.
http://www.nfid.org/hepatitis-b-toolkit
As described before, HBV attacks the healthy cells of the liver causing damage 
that can be short or long term. To help combat these effects, there has been 
research into the use of antivirals for those diagnosed with HBV. The thought 
behind this process is that the use of antivirals could stop or limit the spread of 
the infection. These medications and ideas on how and who they may work for is 
better described in the works of Branstetter-Hall & Felicilda-Reynaldo. They 
discuss the various different types antiviral drugs used to treat chronic 
HBV. These medications are classified as nucleoside reverse transcriptase 
inhibitors (NRTIs) or nonnucleoside reverse transcriptase inhibitors (NNRTIs) 
(2017).
There is also a series of vaccinations that may be given to those a risk. These 
vaccines work the same as many other vaccines in which the body is introduced 
to small amounts of the antibodies from a virus, so that if the body is exposed to 
these antibodies in the future, they have the ability to recognize them and start 
the process of fighting off the infection before it can spread. However, as 
evidenced by the works of Cloherty, Holzmayer, Kuhns, and McNamara, even 
with these vaccines there are chances of breakthrough infection. In their 
work, they studied two samples that were found to be breakthrough infections of 
HBV. In these breakthrough samples, there is a differing sequence of events 
described by the authors as “Vaccine breakthrough infections differ from typical 
acute HBV infection where the order of appearance of viral markers in the 
peripheral blood follows a consistent pattern with hepatitis B viral DNA (HBV 
DNA) followed by HBsAg, hepatitis B e antigen (HBeAg), and antibody to hepatitis 
B core antigen (anti-HBc). Resolution of infection in typical acute infection is 
marked by loss of serum HBsAg and HBV DNA and the appearance of anti-HBs. In 
contrast, during breakthrough infections, HBV DNA becomes detectable in 
vaccinated individuals who have protective levels of anti-HBs” (2019). In the 
works by Avileli, Basireddy, Beldono, & Gundela, they found that increased age, 
smoking, and increase body mass index can all lead to decreased effectiveness of 
the vaccines for HBV (2018).
